iOnctura Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

iOnctura's estimated annual revenue is currently $5M per year.(i)
iOnctura's estimated revenue per employee is $155,000

Employee Data

iOnctura has 32 Employees.(i)

iOnctura's People

Name	Title	Email/Phone
1 Lars Veen	COO	Reveal Email/Phone

iOnctura Competitors & AlternativesAdd Company

Competitor Name	Revenue	Number of Employees	Employee Growth	Total Funding	Valuation
#1 Dermavant Scien...	$81.4M	375	40%	N/A	N/A
#2 Metrum Research...	$16.9M	109	22%	N/A	N/A
#3 Clovis Oncology	$156.1M	120	-70%	$145M	N/A
#4 ArcherDX	$2.9M	37	-24%	$150M	N/A
#5 Inscripta	$1.3M	17	0%	$459.5M	N/A
#6 Cerapedics	$49.2M	254	15%	$180.7M	N/A
#7 Stone Clinical ...	$7M	45	-2%	N/A	N/A
#8 Apellis Pharmac...	$256.3M	840	9%	$168.5M	N/A
#9 CreoSalus	$4.2M	27	-7%	N/A	N/A
#10 MSBiotec	$10.1M	65	5%	N/A	N/A

Add Company

Show More Biotech Companies

What Is iOnctura?

iOnctura, headquartered in Geneva, Switzerland, was founded in June 2017 as a spin out from Merck KGaA, funded by Merck Ventures. It is a late stage preclinical biotechnology company developing a pipeline of next generation, best-in-class molecules for the treatment of cancer and fibrosis. With its programs harnessing both immune-mediated and direct anti-tumour activity iOnctura aims to deliver superior clinical efficacy in oncology. By building on complimentary mechanisms between cancer and fibrosis iOnctura further aims to address high unmet medical need in fibrotic diseases. iOnctura strives to develop differentiated and targeted development strategies based on the latest scientific insights. Through its strong collaborations with Cancer Research UK and the NKI (the Dutch Cancer Institute), iOnctura has access to world renowned experts in the field to support and advance its programs.

keywords:N/A

N/A

Total Funding

Number of Employees

$5M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator